Jaksch Frank L Jr
SEC insider (Form 3/4/5 filer). CIK 0001437237. Director at Niagen Bioscience, Inc. (NAGE). 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 24, 2026. Located in LOS ANGELES, CA.
Companies Jaksch Frank L Jr has filed insider reports for
- Niagen Bioscience, Inc. (NAGE): Director
Jaksch Frank L Jr
CIK: 0001437237
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (25.0%)
Position reduction
Option Exercises (M)1 (25.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NAGE
Niagen Bioscience, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 24, 2026NAGE
Niagen Bioscience, Inc.
AwardDirectStock Option (right to buy)
31.7K shares- - Jun 24, 2025NAGE
Niagen Bioscience, Inc.
AwardDirectStock Option (right to buy)
20K shares- - Dec 13, 2024CDXC
ChromaDex Corp.
ExerciseDirect50K shares at avg. $3.66$183K - Dec 13, 2024CDXC
ChromaDex Corp.
SaleDirect37.2K shares at avg. $6.19$230K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 24, 2026 | NAGE Niagen Bioscience, Inc. | Award Stock Option (right to buy) | 31,746 | - | - | Direct |
| Jun 24, 2025 | NAGE Niagen Bioscience, Inc. | Award Stock Option (right to buy) | 20,000 | - | - | Direct |
| Dec 13, 2024 |  CDXC ChromaDex Corp. | Exercise | 50,001 | $3.66 | $183,004 | Direct |
| Dec 13, 2024 | CDXC ChromaDex Corp. | Sale | 37,161 | $6.19 | $229,956 | Direct |
1-4 of 4 transactions